G1 Therapeutics, Inc.

GTHX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$32,281$94,594$221,186$207,306
Short-Term Investments$49,938$50,476$0$0
Receivables$12,687$11,094$5,688$237
Inventory$12,442$16,179$3,471$0
Other Curr. Assets$7,663$7,157$13,220$8,849
Total Curr. Assets$114,948$179,500$243,565$216,392
Property Plant & Equip (Net)$6,384$7,951$9,048$10,508
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$187$250$312$437
Tax Assets$0$0$0$0
Other NC Assets$21$264$1,169$1,215
Total NC Assets$6,592$8,465$10,529$12,160
Other Assets$0$0$0$0
Total Assets$121,540$187,965$254,094$228,552
Liabilities
Payables$3,992$7,431$2,897$3,572
Short-Term Debt$0$1,135$1,115$0
Tax Payable$0$0$0$0
Deferred Revenue$620$7$31$237
Other Curr. Liab.$25,104$27,015$23,570$19,634
Total Curr. Liab.$29,716$35,588$27,613$23,443
LT Debt$55,897$82,630$81,940$27,758
Deferred Rev, NC$500$1,000$1,000$0
Deferred Tax Liab, NC$4,340-$77,015-$75,190$0
Other NC Liab.$41$0$0$0
Total NC Liab.$56,438$83,630$82,940$27,758
Other Liabilities$0$0$0$0
Cap. Leases$4,340$6,750$7,865$7,865
Total Liabilities$86,154$119,218$110,553$51,201
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$4$4
Retained Earnings-$779,985-$732,018-$584,459-$436,107
AOCI-$0-$0-$0$0
Other Equity$815,366$800,760$727,996$613,454
Total Equity$35,386$68,747-$584,459-$436,107
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$121,540$187,965-$473,906-$384,906
Net Debt$23,616-$10,829-$138,131-$179,548